AFBS is investing in research to bring us closer to treatments for Nemaline Myopathy (NM). Dr. Dowling at SickKids Hospotal is exploring the application of CRISPR/Cas9 to NM therapeutics, and we’re funding his latest research.
Read More
AFBS is investing in research to bring us closer to treatments for Nemaline Myopathy (NM). Dr. Dowling at SickKids Hospotal is exploring the application of CRISPR/Cas9 to NM therapeutics, and we’re funding his latest research.
Read More